References
- Kent N. Pyridinoline/Desoxypyridinoline. Scand J Clin Lab Invest 1997; 57: 73–79, (Suppl 227)
- Robins S P, Duncan A, Wilson A, Evans L E. Standardization of the Pyridinium Crosslinks, Pyridinoline and Deoxypyridinoline, for Use as Biochemical Markers of Collagen Degradation. Clin Chem 1996; 42: 1621–1626
- Vermeers C. Production of Well Defined Homogenous Osteocalcin Standards. Scand J Clin Lab Invest 1997; 57: 10–104, (Suppl 227)
- Szulc P, Chapuy M C, Meunier P J, Delmas P D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769–74
- Garnero P, Grimeaux M, Seguin P., Delmas P D. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994; 9: 225–64
- Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino. Serum Propeptide and Intact Molecular Osteocalcin in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker of Bone Growth and Response to GH Therapy. J Clin Endocrinol Metab 1992; 75: 1104–1109
- Sokol I J, O'Brien M E, Camilo M E, Sadowski J A. Undercarboxylated Osteocalcin and Development of a Method to Determine Vitamin K Status. Clin Chem 1995; 41/8: 1121–8
- Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J. Decreases Serum Osteocalcin Levels in Phenprocoumon-Treated Patients. J Clin Endocrinol Metab 1988; 66: 1071–4
- Delmas P D, Christiansen C, Mann K G, Price P A. Bone Gla Protein (Osteocalcin) Assay Standardization Report. J Bone Miner Res. 1990; 5: 5–11
- Hertz H S. Development of an International Directory of Reference Methods and Reference Materials. Eur J Clin Chem Clin Biochem 1995; 33: 999–1002
- Joffe P, Heaf J G, Hyldstrup L. Osteocalcin: A noninvasive index of metabolic bone disease in patients treated by CAPD. Kidney Int. 1994; 46: 838–846